Harvard

Home/Tag: Harvard

LRG Research Team members publish results of imatinib combination study

Drs. Jonathan Fletcher, of Brigham & Women’s Hospital, Harvard University and Maria Debiec-Rychter, of the Catholic University in Leuven, Belgium, members of the LRG Research Team were part of a recently published study that looked at the effectiveness of GDC-0941, a PI3K inhibitor when used in combination with imatinib (Gleevec).

By |2019-09-20T13:20:42-04:00February 1st, 2013|News, Research|
Go to Top